You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR IOBENGUANE I-131

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for IOBENGUANE I-131

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00126412 ↗	Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma	Completed	GE Healthcare	Phase 3	2005-08-02	The study is designed to study the effectiveness of 123I-mIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroblastoma or phaeochromocytoma.
NCT00126425 ↗	Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease	Completed	GE Healthcare	Phase 3	2005-07-01	The study is designed to study the utility of 123I-mIBG as a diagnostic imaging agent to predict cardiac outcomes in subjects with heart failure and in comparison to subjects without cardiovascular disease.
NCT00126438 ↗	Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease	Completed	GE Healthcare	Phase 3	2005-07-01	The study is designed to study the utility of 123I-mIBG as a diagnostic imaging agent to predict cardiac outcome in subjects with heart failure and in comparison to subjects without cardiovascular disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for IOBENGUANE I-131

Condition Name

Chart
Table

Condition Name for IOBENGUANE I-131
Intervention	Trials
Neuroblastoma	7
Pheochromocytoma	4
Paraganglioma	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for IOBENGUANE I-131
Intervention	Trials
Neuroblastoma	9
Heart Failure	4
Pheochromocytoma	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for IOBENGUANE I-131

Trials by Country

Map
Table

Trials by Country for IOBENGUANE I-131
Location	Trials
United States	120
Canada	6
Puerto Rico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for IOBENGUANE I-131
Location	Trials
Texas	7
Pennsylvania	7
North Carolina	7
Ohio	6
Illinois	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for IOBENGUANE I-131

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for IOBENGUANE I-131
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	4
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for IOBENGUANE I-131
Clinical Trial Phase	Trials
Completed	9
Recruiting	3
Approved for marketing	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for IOBENGUANE I-131

Sponsor Name

Chart
Table

Sponsor Name for IOBENGUANE I-131
Sponsor	Trials
GE Healthcare	5
Molecular Insight Pharmaceuticals, Inc.	5
National Cancer Institute (NCI)	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for IOBENGUANE I-131
Sponsor	Trials
Industry	13
Other	6
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.